Handbook of Stress and the Brain - Part 2: Stress: Integrative and Clinical Aspects

2005 ◽  
Keyword(s):  
Clinical Aspects ◽  
The Brain ◽  
Brain Part

scholarly journals Unlocking the secrets of the brain, part II

BioScience ◽  
1997 ◽  
Vol 47 (7) ◽  
pp. 403-408
Author(s):  
Tabitha M. Powledge
Keyword(s):  
The Brain ◽  
Brain Part

Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1

2015 ◽  
Vol 83 (9) ◽  
pp. 952-964 ◽  
Author(s):  
Sniya Valsa Sudhakar ◽  
Karthik Muthusamy ◽  
Sunithi Mani ◽  
Sridhar Gibikote ◽  
Manohar Shroff
Keyword(s):  
Inflammatory Diseases ◽  
The Brain ◽  
Brain Part

Vision and the brain, part I

2003 ◽  
Vol 21 (2) ◽  
pp. xi-xiii
Author(s):  
Jason J.S. Barton ◽  
Matthew Rizzo
Keyword(s):  
The Brain ◽  
Brain Part

scholarly journals Stationary Potential of the Brain : Part II. Clinical Studies

1979 ◽  
Vol 19 (7) ◽  
pp. 655-664
Author(s):  
Keiji SANO ◽  
Shinya MANAKA ◽  
Hiroyuki MIYAKE ◽  
Yoshiaki MAYANAGI ◽  
Tokuro FUCHINOUE
Keyword(s):  
Clinical Studies ◽  
Stationary Potential ◽  
The Brain ◽  
Brain Part

Brain Grafting as a Treatment for Parkinson's Disease

Neurosurgery ◽  
1987 ◽  
Vol 20 (2) ◽  
pp. 335-342 ◽  
Author(s):  
Mark J. Perlow
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Manifestations ◽  
Dopamine Neurons ◽  
Clinical Aspects ◽  
Pathological Changes ◽  
Pharmacological Treatments ◽  
The Central Nervous System ◽  
The Brain

Abstract Parkinson's disease is an illness with neuropathological and neuroanatomical abnormalities in many areas of the central nervous system. Some clinical manifestations of this illness are correlated with pathological changes in the substantia nigra and with a loss of dopamine in the nigra and striatum. The most effective pharmacological treatments have used agents that either replace the lost dopamine or act as agonists on dopamine receptors. Recent studies in animal models of Parkinson's disease demonstrate that the loss of dopamine and many clinical manifestations of dopamine reduction can be reversed by transplantation of fetal dopamine-containing cells to specific dopamine-depleted areas of the brain. Long term viability of these transplants has also been demonstrated. The author suggests that the transplantation of dopamine neurons, even across species barriers, is a reasonable consideration for the treatment of human Parkinson's disease. This article reviews in detail the results of recent experiments and how the experience in these models might be utilized in determining a transplantation strategy for the treatment of specific clinical aspects of this illness.

Metabolic Disorders of the Brain: Part II

2011 ◽  
Vol 32 (6) ◽  
pp. 615-636 ◽  
Author(s):  
Sangam Kanekar ◽  
Joel Verbrugge
Keyword(s):  
Metabolic Disorders ◽  
The Brain ◽  
Brain Part

scholarly journals Clinical Applications of Stochastic Dynamic Models of the Brain, Part II: A Review

2017 ◽  
Vol 2 (3) ◽  
pp. 225-234 ◽  
Author(s):  
James A. Roberts ◽  
Karl J. Friston ◽  
Michael Breakspear
Keyword(s):  
Dynamic Models ◽  
Clinical Applications ◽  
Stochastic Dynamic ◽  
The Brain ◽  
Brain Part
Sign in / Sign up

Export Citation Format

Share Document